PetMed Express Files 8-K: Board & Compensation Updates
Ticker: PETS · Form: 8-K · Filed: Apr 29, 2024 · CIK: 1040130
| Field | Detail |
|---|---|
| Company | Petmed Express Inc (PETS) |
| Form Type | 8-K |
| Filed Date | Apr 29, 2024 |
| Risk Level | low |
| Pages | 7 |
| Reading Time | 8 min |
| Key Dollar Amounts | $550,000, $120,000, $2.0 million, $750,000, $4.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, filing-update
Related Tickers: PETS
TL;DR
PETS filed an 8-K on 4/29 for board changes and comp. Nothing major yet.
AI Summary
PetMed Express, Inc. filed an 8-K on April 29, 2024, reporting changes in its board of directors and executive compensation arrangements. The filing also includes financial statements and exhibits, indicating ongoing corporate governance and financial disclosures.
Why It Matters
This filing signals potential shifts in the company's leadership and incentive structures, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not contain information about significant financial distress or operational failures.
Key Players & Entities
- PetMed Express, Inc. (company) — Registrant
- April 29, 2024 (date) — Date of earliest event reported
- Florida (location) — State of incorporation
- 420 South Congress Avenue, Delray Beach, Florida 33445 (address) — Principal executive offices
- ( 561 ) 526-4444 (phone_number) — Registrant's telephone number
FAQ
What specific changes were made to the board of directors?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" as an item of disclosure, but the specific names and details of these changes are not provided in the provided text.
What are the details of the compensatory arrangements for certain officers?
The filing lists "Compensatory Arrangements of Certain Officers" as an item, but the specific details of these arrangements are not included in the provided text.
What is the purpose of filing financial statements and exhibits?
The filing includes "Financial Statements and Exhibits" as an item, which is standard for an 8-K to provide supporting documentation for the reported events or to update financial information.
When was PetMed Express, Inc. incorporated?
PetMed Express, Inc. was incorporated in Florida, as indicated by the filing.
What is the company's fiscal year end?
The company's fiscal year ends on March 31st, as stated in the filing.
Filing Stats: 2,094 words · 8 min read · ~7 pages · Grade level 11.2 · Accepted 2024-04-29 08:17:45
Key Financial Figures
- $550,000 — d will receive an annual base salary of $550,000, which may be increased in the discreti
- $120,000 — Campos will receive a signing bonus of $120,000, which is subject to repayment if Ms. C
- $2.0 million — tion Plan for a number of RSUs equal to $2.0 million divided by 2 the closing price of th
- $750,000 — having an aggregate value per grant of $750,000 for the annual RSU grant and $750,000 f
- $4.00 — date of grant but subject to a floor of $4.00 per share. The RSUs included in any suc
Filing Documents
- pets-20240429.htm (8-K) — 40KB
- pets-20240429xexx101.htm (EX-10.1) — 55KB
- pets-20240429xexx102.htm (EX-10.2) — 131KB
- pets-20240429xexx991pressr.htm (EX-99.1) — 15KB
- 0001040130-24-000022.txt ( ) — 414KB
- pets-20240429.xsd (EX-101.SCH) — 2KB
- pets-20240429_lab.xml (EX-101.LAB) — 21KB
- pets-20240429_pre.xml (EX-101.PRE) — 12KB
- pets-20240429_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On April 29, 2024, the Company issued a press release announcing the appointment of Ms. Campos as Chief Executive Officer and President of the Company and the departure of Mr. Hulett. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information in this Item 7.01 and the related information in Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section and shall not be deemed incorporated by reference in any filing made by the Company under the Securities Act or the Exchange Act except as set forth by specific reference in such filing. 3
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Transition and Separation Agreement, dated April 29, 2024, between the Company and Mathew Hulett. 10.2 Executive Employment Agreement, dated April 29, 2024, between the Company and Sandra Campos. 99.1 Press Release dated April 29, 2024 104 Cover Page Interactive Data File (formatted as Inline XBRL) * * * 4
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 29, 2024 PETMED EXPRESS, INC. By: /s/ Christine Chambers Name: Christine Chambers Title: Chief Financial Officer and Treasurer 5